InvestorsHub Logo
Followers 54
Posts 4438
Boards Moderated 0
Alias Born 08/21/2015

Re: jim992 post# 18120

Tuesday, 03/28/2017 7:59:40 AM

Tuesday, March 28, 2017 7:59:40 AM

Post# of 74170
DFCON is an educational conference focused on diabetic foot problems and solutions. Their website has everything anyone needs to know to understand the purpose. Livestream was available--perhaps for a price.

Dfcon.com

There is a stickie that mentions an acquaintance who attended. Otiko was in a room with about 20 other abstract poster presenters. He offered product samples to interested persons. He was not a speaker.

The product Otiko used in his abstract is available from at least one other competitor business under a different brand name. In a nearly identical formulation, Diabecline won an award in 2012 (see ibox table comparing Diabecline and Viabecline).

The underlying transdermal delivery system is patent-pending (Phillips/Keough). Otiko has a non-exclusive license to market and distribute Viabecline which is based on this system.

Read the last filing carefully to better understand this company. The Annual Report is due this week.